Case Study: Inhibrx achieves centralized biologics data and accelerated IND filing with Benchling

Centralizing Biologics Data for a Growing Company

Inhibrx develops multivalent costimulatory agonists, checkpoint inhibitors, and other therapeutics to shift the tumor microenvironment toward local immune activation. The company struggled with fragmented plasmid maps stored on individual scientists’ computers, spreadsheet-based request tracking, and a shared paper lab notebook, all of which made locating plasmids, tracking requests, and extracting experimental insights slow and error-prone.

Benchling centralized Inhibrx’s biologics data with a Bioregistry that enforces unique plasmid registration, links batches to experimental notes, and gives new teams access to upstream data. Using Benchling Lab Notebook entries and unique IDs also streamlined IND filing, saving months of effort while improving data integrity and discoverability across the growing organization.

Inhibrx